Search details
1.
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
J Antimicrob Chemother
; 78(11): 2752-2761, 2023 11 06.
Article
in English
| MEDLINE | ID: mdl-37807834
2.
Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
Colorectal Dis
; 25(3): 386-395, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36268758
3.
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature.
Infection
; 49(3): 549-553, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33074365
4.
Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.
Anticancer Drugs
; 26(8): 878-83, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26053279
5.
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.
Anticancer Drugs
; 26(8): 884-7, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26053281
6.
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.
Future Oncol
; 11(18): 2563-74, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26314701
7.
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer.
Anticancer Drugs
; 25(4): 472-7, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24394473
8.
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?
Biomedicines
; 12(2)2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38397990
9.
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.
Aging Clin Exp Res
; 30(6): 677-680, 2018 06.
Article
in English
| MEDLINE | ID: mdl-28856577
10.
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis.
Anticancer Res
; 43(2): 755-763, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36697101
11.
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study.
J Clin Med
; 12(12)2023 Jun 15.
Article
in English
| MEDLINE | ID: mdl-37373748
12.
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study).
JAC Antimicrob Resist
; 4(3): dlac064, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35719203
13.
Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs.
Antibiotics (Basel)
; 10(10)2021 Oct 08.
Article
in English
| MEDLINE | ID: mdl-34680805
14.
Tolerability of single-agent sorafenib in the treatment of elderly patients with hepatocellular carcinoma (HCC).
Hepatology
; 60(2): 764-5, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25187926
15.
Selective parallel integration of individual metallic single-walled carbon nanotubes from heterogeneous solutions.
Langmuir
; 26(13): 10419-24, 2010 Jul 06.
Article
in English
| MEDLINE | ID: mdl-20527829
16.
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival.
Anticancer Drugs
; 26(8): 910-1, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26207428
17.
Forecasting Energy Consumption in the EU Residential Sector.
Int J Environ Res Public Health
; 17(7)2020 03 27.
Article
in English
| MEDLINE | ID: mdl-32230879
18.
Measles in pregnant women: A systematic review of clinical outcomes and a meta-analysis of antibodies seroprevalence.
J Infect
; 80(2): 152-160, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31891729
19.
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development.
Cancer Chemother Pharmacol
; 85(1): 9-20, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31512029
20.
[Bevacizumab e altri farmaci. Attività e sicurezza degli agenti anti-VEGF nel carcinoma ovarico.] / Bevacizumab and others. Activity and safety of anti-VEGF agents in ovarian cancer.
Recenti Prog Med
; 110(7): 330-337, 2019.
Article
in Italian
| MEDLINE | ID: mdl-31379367